Clinical trial

Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8

NCT00218036 · The University of Texas Health Science Center, Houston, Other · Terminated

Key facts

NCT number NCT00218036
Title Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8
Official title Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals
Lead sponsor The University of Texas Health Science Center, Houston, Other
Collaborators National Institute on Drug Abuse (NIDA) NIH University of Texas
Status Terminated
Phase Phase 2
Study type Interventional
Conditions Cocaine Abuse, Opiate Dependence
Intervention type Drug
Interventions Modafinil 200mg, Modafinil 400mg, Citalopram 20mg, Citalopram 40mg, Placebo
Enrollment 54
Start date Jul 1, 2006
Primary completion Feb 1, 2010
Completion Feb 1, 2010
First posted Sep 22, 2005
Last update posted Nov 16, 2018
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies